NCT07342504 Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
| NCT ID | NCT07342504 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Notre Dame |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-03-24 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-03-24 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.
Eligibility Criteria
Inclusion Criteria for the RCT: * Participants must be taking prescribed buprenorphine for at least 2 weeks * Participants must be 18 years or older. * Meet DSM-5 criteria for alcohol use disorder (AUD) * Participants must report alcohol use ≥ 1 day/week on average in the past 28 days * Participants must be able to read simple English Exclusion Criteria: * Currently receiving formal alcohol use treatment. * Currently experiencing psychosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07342504 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342504 currently recruiting?
Yes, NCT07342504 is actively recruiting participants. Contact the research team at ryancarpenter@nd.edu for enrollment information.
Where is the NCT07342504 trial being conducted?
This trial is being conducted at Notre Dame, United States.
Who is sponsoring the NCT07342504 clinical trial?
NCT07342504 is sponsored by University of Notre Dame. The trial plans to enroll 60 participants.